PE20011005A1 - COMBINATIONS OF A PHOSPHODIESTERASE 4 INHIBITOR AND A STEROID ANTI-INFLAMMATORY FOR THE TREATMENT OF PULMONARY DISEASES - Google Patents
COMBINATIONS OF A PHOSPHODIESTERASE 4 INHIBITOR AND A STEROID ANTI-INFLAMMATORY FOR THE TREATMENT OF PULMONARY DISEASESInfo
- Publication number
- PE20011005A1 PE20011005A1 PE2000001168A PE0011682000A PE20011005A1 PE 20011005 A1 PE20011005 A1 PE 20011005A1 PE 2000001168 A PE2000001168 A PE 2000001168A PE 0011682000 A PE0011682000 A PE 0011682000A PE 20011005 A1 PE20011005 A1 PE 20011005A1
- Authority
- PE
- Peru
- Prior art keywords
- phosphodiesterase
- inhibitor
- pulmonary diseases
- inflammatory
- combinations
- Prior art date
Links
- 208000019693 Lung disease Diseases 0.000 title abstract 2
- 229940123932 Phosphodiesterase 4 inhibitor Drugs 0.000 title 1
- 230000003110 anti-inflammatory effect Effects 0.000 title 1
- 239000002587 phosphodiesterase IV inhibitor Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- MSYGAHOHLUJIKV-UHFFFAOYSA-N 3,5-dimethyl-1-(3-nitrophenyl)-1h-pyrazole-4-carboxylic acid ethyl ester Chemical compound CC1=C(C(=O)OCC)C(C)=NN1C1=CC=CC([N+]([O-])=O)=C1 MSYGAHOHLUJIKV-UHFFFAOYSA-N 0.000 abstract 1
- KUVIULQEHSCUHY-XYWKZLDCSA-N Beclometasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(Cl)[C@@H]1[C@@H]1C[C@H](C)[C@@](C(=O)COC(=O)CC)(OC(=O)CC)[C@@]1(C)C[C@@H]2O KUVIULQEHSCUHY-XYWKZLDCSA-N 0.000 abstract 1
- 101100296719 Caenorhabditis elegans pde-4 gene Proteins 0.000 abstract 1
- 102000011017 Type 4 Cyclic Nucleotide Phosphodiesterases Human genes 0.000 abstract 1
- 108010037584 Type 4 Cyclic Nucleotide Phosphodiesterases Proteins 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 239000003470 adrenal cortex hormone Substances 0.000 abstract 1
- 229960004495 beclometasone Drugs 0.000 abstract 1
- RKHQGWMMUURILY-UHRZLXHJSA-N cortivazol Chemical compound C([C@H]1[C@@H]2C[C@H]([C@]([C@@]2(C)C[C@H](O)[C@@H]1[C@@]1(C)C2)(O)C(=O)COC(C)=O)C)=C(C)C1=CC1=C2C=NN1C1=CC=CC=C1 RKHQGWMMUURILY-UHRZLXHJSA-N 0.000 abstract 1
- 229960002714 fluticasone Drugs 0.000 abstract 1
- MGNNYOODZCAHBA-GQKYHHCASA-N fluticasone Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@@H](C)[C@@](C(=O)SCF)(O)[C@@]2(C)C[C@@H]1O MGNNYOODZCAHBA-GQKYHHCASA-N 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 229960002744 mometasone furoate Drugs 0.000 abstract 1
- WOFMFGQZHJDGCX-ZULDAHANSA-N mometasone furoate Chemical compound O([C@]1([C@@]2(C)C[C@H](O)[C@]3(Cl)[C@@]4(C)C=CC(=O)C=C4CC[C@H]3[C@@H]2C[C@H]1C)C(=O)CCl)C(=O)C1=CC=CO1 WOFMFGQZHJDGCX-ZULDAHANSA-N 0.000 abstract 1
- 229960002117 triamcinolone acetonide Drugs 0.000 abstract 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE AL USO DE UNA COMBINACION QUE COMPRENDE:UN INHIBIDOR DE FOSFODIESTERASA 4 (PDE 4) TAL COMO EL ACIDO CIS-4-CIANO-(3-CICLOPENTILOXI-4-METOXIFENIL)CICLOHEXANO-1-CARBOXILICO Y UN CORTICOIDE TAL COMO DEXAMETASONA, FLUTICASONA, BECLOMETASONA, BUDENOSINA, FLUNICOLIDA, FUROATO DE MOMETASONA, ACETONIDO DE TRIAMCINOLONA; LOS QUE SE ADMINISTRAN JUNTOS O POR SEPARADO. LA COMBINACION PUEDE SER UTIL PARA PREVENIR O REDUCIR ENFERMEDADES PULMONARESIT REFERS TO THE USE OF A COMBINATION THAT INCLUDES: A PHOSPHODIESTERASE 4 (PDE 4) INHIBITOR SUCH AS CIS-4-CYANE- (3-CYCLOPENTILOXY-4-METOXYPHENYL) CYCLOHEXAN-1-CARBOXAMYLONE ACID, AND A CORTICOID THAX FLUTICASONE, BECLOMETASONE, BUDENOSINE, FLUNICOLIDE, MOMETASONE FUROATE, TRIAMCINOLONE ACETONIDE; THOSE THAT ARE ADMINISTERED TOGETHER OR SEPARATELY. THE COMBINATION MAY BE USEFUL TO PREVENT OR REDUCE PULMONARY DISEASES
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16315899P | 1999-11-02 | 1999-11-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20011005A1 true PE20011005A1 (en) | 2001-09-28 |
Family
ID=22588737
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2000001168A PE20011005A1 (en) | 1999-11-02 | 2000-11-02 | COMBINATIONS OF A PHOSPHODIESTERASE 4 INHIBITOR AND A STEROID ANTI-INFLAMMATORY FOR THE TREATMENT OF PULMONARY DISEASES |
Country Status (29)
| Country | Link |
|---|---|
| EP (1) | EP1225866A4 (en) |
| JP (1) | JP2003513028A (en) |
| KR (1) | KR20020057988A (en) |
| CN (1) | CN1387404A (en) |
| AP (1) | AP2002002496A0 (en) |
| AR (1) | AR029189A1 (en) |
| AU (1) | AU1357501A (en) |
| BG (1) | BG106748A (en) |
| BR (1) | BR0015270A (en) |
| CA (1) | CA2388333A1 (en) |
| CO (1) | CO5261512A1 (en) |
| CZ (1) | CZ20021512A3 (en) |
| DZ (1) | DZ3225A1 (en) |
| EA (1) | EA200200518A1 (en) |
| EC (1) | ECSP003747A (en) |
| HK (1) | HK1049107A1 (en) |
| HU (1) | HUP0203152A3 (en) |
| IL (1) | IL149367A0 (en) |
| MA (1) | MA26841A1 (en) |
| MX (1) | MXPA02004350A (en) |
| NO (1) | NO20022057L (en) |
| OA (1) | OA12076A (en) |
| PE (1) | PE20011005A1 (en) |
| PL (1) | PL355261A1 (en) |
| SK (1) | SK7592002A3 (en) |
| TR (1) | TR200201211T2 (en) |
| TW (1) | TWI242431B (en) |
| WO (1) | WO2001032127A2 (en) |
| ZA (1) | ZA200203435B (en) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL160271A0 (en) | 2001-09-19 | 2004-07-25 | Altana Pharma Ag | Pharmaceutical compositions containing pde4-inhibitors and nsaid |
| HUP0401984A3 (en) * | 2001-10-31 | 2005-06-28 | Merck Patent Gmbh | Use of type 4 phosphodiesterase inhibitors for preparation of pharmaceutical compositions and combination with other active ingredients |
| UA82323C2 (en) * | 2002-08-09 | 2008-04-10 | Меда Фарма Гмбх & Ко. Кг | Novel combination of a glucocorticoid and pde-inhibitor for the treatment of respiratory diseases, allergic diseases, asthma and chronic obstructive pulmonary diseases |
| TW200410923A (en) * | 2002-10-17 | 2004-07-01 | Ono Pharmaceutical Co | Therapeutic agent for chronic obstructive pulmonary disease |
| EP1616569A1 (en) * | 2003-03-31 | 2006-01-18 | Kyowa Hakko Kogyo Co., Ltd. | Medicinal composition |
| US20050026883A1 (en) * | 2003-07-31 | 2005-02-03 | Robinson Cynthia B. | Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a PDE-4 inhibitor for treatment of asthma or chronic obstructive pulmonary disease |
| US20070287689A1 (en) * | 2004-10-13 | 2007-12-13 | Kyowa Hakko Kogyo Co., Ltd. | Therapeutic And/Or Preventive Agents For Chronic Skin Diseases |
| US20090054382A1 (en) * | 2005-10-19 | 2009-02-26 | Abhijit Ray | Compositions of phosphodiesterase type iv inhibitors |
| US8991390B2 (en) | 2010-01-05 | 2015-03-31 | Microdose Therapeutx, Inc. | Inhalation device and method |
| WO2015063669A1 (en) | 2013-10-30 | 2015-05-07 | Wockhardt Limited | Pharmaceutical compositions comprising combination of roflumilast and acebrophylline or pharmaceutically acceptable salts thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0710109B1 (en) * | 1993-06-18 | 2004-09-15 | Smithkline Beecham Corporation | Method for identifying a PDE IV inhibitor |
| DE4332041C2 (en) * | 1993-09-21 | 1997-12-11 | Rentschler Arzneimittel | Use of pentoxifylline in certain lung diseases |
| PE44995A1 (en) * | 1994-01-27 | 1995-12-18 | Schering Corp | MOMETASONE FUROATE FOR THE TREATMENT OF LUNG DISEASES AND RESPIRATORY TRACT |
| SE9801368D0 (en) * | 1998-04-20 | 1998-04-20 | Astra Ab | New use |
-
2000
- 2000-10-31 EC EC2000003747A patent/ECSP003747A/en unknown
- 2000-10-31 AR ARP000105742A patent/AR029189A1/en not_active Application Discontinuation
- 2000-11-01 HK HK02109234.5A patent/HK1049107A1/en unknown
- 2000-11-01 WO PCT/US2000/030113 patent/WO2001032127A2/en not_active Ceased
- 2000-11-01 AP APAP/P/2002/002496A patent/AP2002002496A0/en unknown
- 2000-11-01 MX MXPA02004350A patent/MXPA02004350A/en unknown
- 2000-11-01 SK SK759-2002A patent/SK7592002A3/en unknown
- 2000-11-01 EA EA200200518A patent/EA200200518A1/en unknown
- 2000-11-01 OA OA1200200124A patent/OA12076A/en unknown
- 2000-11-01 KR KR1020027005609A patent/KR20020057988A/en not_active Ceased
- 2000-11-01 BR BR0015270-6A patent/BR0015270A/en not_active IP Right Cessation
- 2000-11-01 AU AU13575/01A patent/AU1357501A/en not_active Abandoned
- 2000-11-01 PL PL00355261A patent/PL355261A1/en not_active Application Discontinuation
- 2000-11-01 CZ CZ20021512A patent/CZ20021512A3/en unknown
- 2000-11-01 CA CA002388333A patent/CA2388333A1/en not_active Abandoned
- 2000-11-01 TR TR2002/01211T patent/TR200201211T2/en unknown
- 2000-11-01 JP JP2001534335A patent/JP2003513028A/en active Pending
- 2000-11-01 IL IL14936700A patent/IL149367A0/en unknown
- 2000-11-01 HU HU0203152A patent/HUP0203152A3/en unknown
- 2000-11-01 CN CN00815265A patent/CN1387404A/en active Pending
- 2000-11-01 DZ DZ003225A patent/DZ3225A1/en active
- 2000-11-01 EP EP00975533A patent/EP1225866A4/en not_active Withdrawn
- 2000-11-02 CO CO00083427A patent/CO5261512A1/en not_active Application Discontinuation
- 2000-11-02 PE PE2000001168A patent/PE20011005A1/en not_active Application Discontinuation
- 2000-11-22 TW TW089123039A patent/TWI242431B/en not_active IP Right Cessation
-
2002
- 2002-04-30 ZA ZA200203435A patent/ZA200203435B/en unknown
- 2002-04-30 NO NO20022057A patent/NO20022057L/en not_active Application Discontinuation
- 2002-05-02 MA MA26621A patent/MA26841A1/en unknown
- 2002-05-29 BG BG106748A patent/BG106748A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BR0015270A (en) | 2002-06-18 |
| WO2001032127A3 (en) | 2001-12-06 |
| KR20020057988A (en) | 2002-07-12 |
| MA26841A1 (en) | 2004-12-20 |
| IL149367A0 (en) | 2002-11-10 |
| HK1049107A1 (en) | 2003-05-02 |
| BG106748A (en) | 2003-02-28 |
| JP2003513028A (en) | 2003-04-08 |
| HUP0203152A3 (en) | 2004-06-28 |
| DZ3225A1 (en) | 2001-05-10 |
| EP1225866A4 (en) | 2004-04-21 |
| EA200200518A1 (en) | 2002-10-31 |
| SK7592002A3 (en) | 2002-11-06 |
| OA12076A (en) | 2006-05-04 |
| WO2001032127A2 (en) | 2001-05-10 |
| TR200201211T2 (en) | 2002-08-21 |
| HUP0203152A2 (en) | 2003-01-28 |
| CA2388333A1 (en) | 2001-05-10 |
| TWI242431B (en) | 2005-11-01 |
| PL355261A1 (en) | 2004-04-05 |
| CN1387404A (en) | 2002-12-25 |
| CZ20021512A3 (en) | 2003-04-16 |
| AU1357501A (en) | 2001-05-14 |
| AR029189A1 (en) | 2003-06-18 |
| MXPA02004350A (en) | 2002-11-07 |
| EP1225866A2 (en) | 2002-07-31 |
| NO20022057D0 (en) | 2002-04-30 |
| ZA200203435B (en) | 2003-06-25 |
| AP2002002496A0 (en) | 2002-06-30 |
| ECSP003747A (en) | 2002-05-23 |
| NO20022057L (en) | 2002-06-27 |
| CO5261512A1 (en) | 2003-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR032471A1 (en) | DERIVED FROM ANDROSTAN AND SOLVATOS OF THE SAME, ITS USE FOR THE MANUFACTURE OF MEDICINES, PHARMACEUTICAL COMPOSITIONS THAT INCLUDE THEM, PROCESSES TO PREPARE SUCH DERIVATIVES, USEFUL INTERMEDIARIES IN THE PREPARATION OF SUCH DERIVATIVES, PROCESSES TO PREPARE SUCH INTERMEDIATES | |
| NO20075660L (en) | Composition for the treatment of inflammatory diseases | |
| HRP20050781B1 (en) | METHODS AND PHARMACEUTICAL MIXTURES FOR RELIABLE ACHIEVEMENT OF ACCEPTABLE TESTOSTERONE LEVELS IN SERUM | |
| UY26977A1 (en) | IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI-INFLAMMATORY AND ANALGESIC AGENTS | |
| TW200837074A (en) | Extended triterpene derivatives | |
| PE34998A1 (en) | A NASAL ATOMIZER CONTAINING AN INTRANASAL STEROID AND AN ANTIHISTAMINE | |
| CO5140098A1 (en) | COMBINATIONS OF A BETRA-2 AGONIST AND A STEROID, ITS USE FOR THE TREATMENT OF INFLAMMATORY OR OBSTRUCTIVE DISEASES OF THE AIRWAYS | |
| ES2152222T3 (en) | SULFONAMIDS, ITS PREPARATION AND ITS USE AS MEDICINAL AND INTERMEDIATE. | |
| BR0111206A (en) | Arylmethylamine derivatives for use as tryptase inhibitors | |
| CL2004001170A1 (en) | INHALABLE PHARMACEUTICAL COMBINATION CONTAINING (A) FORMOTEROL, OR A SALT, OR A SOLVATE OF IT OR THE SALT AND (B) MOMETASONE FUROATE; PHARMACEUTICAL CASE THAT UNDERSTANDS IT; AND ITS USE IN THE THERAPY OF AN INFLAMMATORY OR OBSTRUCTIVE DISEASE OF THE V | |
| ES2052603T3 (en) | DERIVATIVES OF BENCIMIDAZOLE, PROCEDURE FOR ITS PRODUCTION AND PHARMACEUTICAL COMPOSITION THAT CONTAIN THEM. | |
| DE60105448D1 (en) | SOLID DISPERSIONS WITH NITRATIVE ACTIVE INGREDIENTS | |
| PE20011005A1 (en) | COMBINATIONS OF A PHOSPHODIESTERASE 4 INHIBITOR AND A STEROID ANTI-INFLAMMATORY FOR THE TREATMENT OF PULMONARY DISEASES | |
| ES2152670T3 (en) | DERIVATIVES OF NITRITE AND NITRATE USEFUL STEROIDS AS ANTI-INFLAMMATORY PHARMACOS. | |
| PE20040068A1 (en) | ETONOGESTREL DECANOATE, UNDECANOATE AND DODECANOATE | |
| GT200100201A (en) | DERIVATIVES OF PIRAZOL FOR THE TREATMENT DER VIRIC DISEASES. | |
| CR6824A (en) | ARYLMETHYLAMINE DERIVATIVES FOR USE AS TRIPTASE INHIBITORS | |
| ES2188426B1 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PSORIASIS AND OTHER DERMOPATIAS. | |
| DK279790A (en) | AROMATIC STEROID-5-ALFA REDUCTASE INHIBITORS | |
| PT912185E (en) | NEW PHARMACEUTICAL FORMULATIONS CONTAINING ESTER NITRATE DERIVATIVES FROM PROVIDED ESTEROIDS AS ANTI-INFLAMMATORY DRUGS | |
| CL2019003562A1 (en) | Steroid derivatives with therapeutic activity. | |
| PE20020793A1 (en) | PREVENTIVE AND / OR THERAPEUTIC AGENT OF INFLAMMATORY DISEASES OF THE RESPIRATORY TRACT | |
| MX9304503A (en) | ANTI-INFLAMMATORY COMPOUNDS. | |
| ECSP034470A (en) | 6.ALFA., 9.ALFA-DIFLUOR-17.ALFA.- (2-FURANILCARBOXILO) OXY-11.BETA.-HIDROXI-16.ALFA.-METIL-3-OXO-ANDROST-1,4, -DIENE- 17-S-FLUORMETILE ESTER CARBOTIOTIC ACID AS AN ANTI-INFLAMMATORY AGENT | |
| ES2165948T3 (en) | THERMOSTABLE CRYSTAL MODIFICATION AND SUITABLE FOR STORAGE OF N-METHYL-N - ((1S) -1-PHENYL-2 - ((3S) -3-HIDROXI-PIRROLIDIN-1-IL) -ETIL) -2,2-DIFENIL- ACETAMIDE, AND PROCEDURE FOR OBTAINING. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |